INTRODUCTION {#s1}
============

Chronic kidney disease (CKD), characterized by reduced glomerular filtration rate (GFR) or abnormal urinary albumin excretion \[[@R1], [@R2]\], is regarded as a part of a subclinical and generalized atherothrombosis \[[@R3]\]. It is seemed as a silent killer due to very mild symptoms and going unnoticed for a long time. Epidemiological investigation showed that the prevalence of CKD is approximately from 8% to 16% in various regions \[[@R4]--[@R8]\]. Now CKD is increasingly common in both developed and developing countries and rapidly becoming a global public health concern.

CKD is deemed to share many traditional atherosclerosis risk factors including diabetes, hypertension, and smoking with cardiovascular diseases \[[@R9]--[@R11]\]. However, these traditional risk factors cannot fully account for this high prevalence of CKD. Other non-traditional risk factors such as endothelial dysfunction, hemodynamic, and chronic inflammation have increasingly been studied \[[@R3], [@R12], [@R13]\].

It is known that the endothelium is highly distributed among all organ systems \[[@R14]\]. Due to the specialized and variable nature of the endothelium, the kidney tends to be a target organ in systemic disease \[[@R15]\]. It has been shown that renal function is closely related to endothelial dysfunction in an elderly general population with mildly impaired renal function \[[@R16]\].

Wall shear stress (WSS), also called endothelial shear stress, is one of the most important hemodynamic forces that are exerted by circulating blood on the endothelial cell layer of the inner vessel wall \[[@R17], [@R18]\]. It represents the tangential force per unit area exerted by flowing blood on the endothelial surface of the vascular wall and plays an important role in vascular remodeling and atherogenesis \[[@R19], [@R20]\]. Different WSSs are thought to have different effects on vascular activities \[[@R20], [@R21]\]. Generally, low or oscillatory WSS is regarded as a reliable indicator for vascular endothelial dysfunction \[[@R17]--[@R21]\].

Some studies \[[@R22], [@R23]\] have investigated the correlation renal function with either carotid artery WSS or brachial artery WSS in recent decades. However, the findings were inconsistencies. The possible relationship between local WSS and renal function has not been fully explored and illuminated although there are some studies made lots of efforts \[[@R22]--[@R25]\].

As a well established "observation window" for systemic structure and arterial function in humans and supplies a very precise regulation of blood flow \[[@R26]\], the common carotid artery (CCA) WSS may also represent the overall hemodynamic condition of the renal vessels \[[@R22], [@R25]\]. We hypothesized that carotid WSS is independently correlated with renal function in the elderly. And, in some extent, carotid WSS may be an important predictive factor of mildly impaired renal function. The main goal of the present study was to investigate and illuminate this relationship.

RESULTS {#s2}
=======

Demographic and clinical characteristics {#s2_1}
----------------------------------------

The demographic and clinical characteristics of all subjects are summarized in Table [1](#T1){ref-type="table"}. The interquartile of mean WSS was \<0.85, 0.85-1.06, 1.07-1.26, and \>1.26 Pa, and peak WSS was \<1.49, 1.49-1.82, 1.83-2.15, and \>2.15 Pa.

###### Clinical and biochemical characteristics of total participants

  Clinical parameters                                Value
  -------------------------------------------------- -------------------------
   Age, years                                        70.70±6.15
   Sex, Female:Male                                  380:381
   Systolic blood pressure, mm Hg                    141.33±13.72
   Diastolic blood pressure, mm Hg                   69.73±7.05
   Body mass index, kg/m^2^                          24.31±2.86
  Biochemical parameters                             
   Total cholesterol, mmol/L                         4.57±0.66
   Triglycerides, mmol/L                             1.45±0.34
   High-density lipoprotein cholesterol, mmol/L      1.14±0.18
   Low- density lipoprotein cholesterol, mmol/L      2.77±0.63
   Fasting plasma glucose, mmol/L                    5.303±0.91
   Creatinine, mg/dl                                 0.78 (0.66, 0.91)
   Cystatin C, mg/L                                  093±0.21
   Urinary albumin, mg/L                             1.26 (0.81, 1.92)
  Covariates                                         
   Smoking, *n* (%)                                  178 (23.39)
   Alcohol intake, *n* (%)                           311 (40.87)
   Hypertension, *n* (%)                             489 (64.26)
   Antihypertensive medication, *n* (%)              445 (91.00)
   Diabetes, *n* (%)                                 93 (12.22)
   Lowering glucose medication, *n* (%)              87 (93.55)
   Dyslipidemia, *n* (%)                             220 (28.91)
   Anti-dyslipidemia medication, *n* (%)             108 (19.09)
   Carotid plaque, *n* (%)                           262 (34.43)
  Carotid wall shear stress                          
   Carotid mean wall shear stress, Pa                1.06±0.28
   Carotid peak wall shear stress, Pa                1.84±0.45
  Endothelial function and inflammatory parameters   
   Brachial artery flow-mediated dilation, %         11.84±3.03
   Nitric oxide, μmol/L                              63.08±14.50
   Endothelin-1, pg/ml                               42.28±9.09
   Intercellular adhesion molecule-1, ng/ml          140.39±35.30
   Vascular cell adhesion molecule-1, ng/ml          613.58 (544.56, 699.06)
  Renal function parameters                          
   eGFR~Cr~, ml·min^-1^·1.73m^-2^                    82.52±17.48
   eGFR~CysC~, ml·min^-1^·1.73m^-2^                  81.48±20.77
   eGFR~Cr-CysC~, ml·min^-1^·1.73m^-2^               83.17±18.96
   Albumin/creatinine ratio, mg/g                    17.59±7.25

Continuous data are expressed as mean ± standard deviation or as median with interquartile range depending on the normality of the data. Categorical data are expressed as numbers (percentages). eGFR~Cr~ indicates estimated glomerular filtration rate base on creatinine; eGFR~CysC~, estimated glomerular filtration rate base on cystatin C; eGFR~Cr-CysC~, estimated glomerular filtration rate base on creatinine and cystatin C.

Table [2](#T2){ref-type="table"} shows the demographic and clinical characteristics of subjects grouped by interquartile of mean WSS. The brachial artery flow-mediated dilation (FMD) and serum nitric oxide (NO) significantly increased, and the serum endothelin-1 (ET-1) and intercellular adhesion molecule-1 (ICAM-1) decreased from Q1 to Q4 according to the respective group. The differences were significant between any two groups (all *P* \<0.05). The vascular cell adhesion molecule-1 (VCAM-1) was markedly lower in Q4 than in Q1, Q2, and Q3, and lower in Q2 and Q3 than in Q1 (all *P* \<0.05).

###### Clinical and biochemical characteristics of participants grouped by the interquartile of carotid mean wall shear stress

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                    Q1\                       Q2\                           Q3\                           Q4\                               *P* value
                                    (*n*=192)                 (*n*=189)                     (*n*=190)                     (*n*=190)                         
  --------------------------------- ------------------------- ----------------------------- ----------------------------- --------------------------------- -----------
  Clinical parameters                                                                                                                                       

   Age, years                       72.33±6.29                71.91±6.07                    70.15±6.10^\*,†^              68.41±5.33^\*,†^                  \<0.001

   Sex, Male:Female                 95:97                     99:90                         93:97                         94:96                             0.907

   BMI, kg/m^2^                     24.73±2.80                24.41±2.90                    24.23±3.01                    23.89±2.68^\*^                    0.037

   SBP, mm Hg                       146.28±13.49              142.67±12.74^\*^              140.86±13.39^\*^              135.47±13.07^\*,†,‡^              \<0.001

   DBP, mm Hg                       69.82±7.29                70.65±6.75                    68.97±7.12                    69.48±6.97                        0.129

  Biochemical parameters                                                                                                                                    

   TCHO, mmol/L                     4.61±0.68                 4.60±0.65                     4.57±0.64                     4.51±0.66                         0.509

   TG, mmol/L                       1.46±0.38                 1.43±0.33                     1.46±0.33                     1.45±0.34                         0.852

   HDL-c, mmol/L                    1.12±0.17                 1.11±0.18                     1.14±0.18                     1.16±0.19                         0.246

   LDL-c, mmol/L                    2.82±0.67                 2.81±0.63                     2.76±0.61                     2.70±0.62                         0.208

   FPG, mmol/L                      5.38±0.95                 5.44±1.02                     5.30±0.92                     5.18±0.74^\*^                     0.033

   Cr, mg/dl                        0.85 (0.71, 1.06)         0.82 (0.70, 0.96)^\*^         0.78 (0.64, 0.89)^\*,†^       0.8 (0.60, 0.79)^\*,†,‡^          \<0.001

   Cys C, mg/L                      1.03±0.17                 0.98±0.21^\*^                 0.93±0.19^\*^                 0.78±0.18^\*,†,‡^                 \<0.001

   UA, mg/L                         1.92 (1.38, 2.82)         1.42 (0.96, 2.07)^\*^         1.13 (0.80, 1.72)^\*,†^       0.78 (0.54, 1.05)^\*,†,‡^         \<0.001

  Covariates                                                                                                                                                

   Current smoker, *n* (%)          36 (18.75)                50 (26.46)                    46 (24.21)                    46 (24.21)                        0.329

   Alcohol consumption, *n* (%)     54 (28.13)                83 (43.92)^\*^                83 (43.68)^\*^                89 (46.84)^\*^                    0.001

   Hypertension, *n* (%)            146 (76.04)               133 (70.37)                   117 (61.58)^\*^               93 (48.95)^\*,†,‡^                \<0.001

   Antihypertension, *n* (%)        133 (91.10)               121 (90.98)                   106 (90.60)                   84 (90.32)                        0.997

   Diabetes, *n* (%)                21 (10.94)                25 (13.23)                    26 (13.68)                    21 (11.05)                        0.855

   Antidiabetes, *n* (%)            20 (95.24)                22 (88.00)                    25 (96.15)                    20 (95.24)                        0.622

   Dyslipidemia, *n* (%)            58 (30.21)                49 (25.93)                    53 (27.89)                    60 (31.58)                        0.630

   Anti-dyslipidemia, *n* (%)       31 (53.45)                26 (53.06)                    24 (45.28)                    27 (45.00)                        0.692

   Carotid plaque, *n* (%)          112 (58.33)               68 (35.98) ^\*^               63 (33.16) ^\*^               19 (10.00) ^\*,†,‡^               \<0.001

  Endothelial function parameters                                                                                                                           

   Brachial artery FMD, %           9.56±2.44                 11.01±2.47^\*^                12.44±2.57^\*,†^              14.39±2.30^\*,†,‡^                \<0.001

   NO, μmol/L                       51.39±11.93               60.17±10.70^\*^               65.14±11.84^\*,†^             75.71±11.63^\*,†,‡^               \<0.001

   ET-1, pg/ml                      49.06±8.24                44.13±8.20^\*^                40.58±7.24^\*,†^              35.27±6.46^\*,†,‡^                \<0.001

   ICAM-1, ng/ml                    164.00±37.21              143.59±33.03^\*^              132.31±29.49^\*,†^            121.45±25.58^\*,†,‡^              \<0.001

   VCAM-1, ng/ml                    674.94 (605.92, 766.98)   636.59 (582.91, 708.31)^\*^   613.58 (550.73, 699.30)^\*^   544.56 (480.19, 613.58)^\*,†,‡^   \<0.001
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data are mean±standard deviation or number (percentage). Q1 indicates the first interquartile; Q2, the second interquartile; Q3, the third interquartile; Q4, the forth interquartile; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TCHO, total cholesterol; TG, triglycerides; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; Cr, creatinine; Cys C, cystatin C; UA, Urinary albumin; FMD, flow-mediated dilation; NO, nitric oxide; ET-1, endothelin-1; ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular cell adhesion molecule-1. ^\*^*P* \<0.05, as compared to Q1; ^†^*P* \<0.05, as compared to Q2; ^‡^*P* \<0.05, as compared to Q3.

[Supplementary Table 1](#SD1){ref-type="supplementary-material"} shows the demographic and clinical characteristics of subjects grouped by interquartile of peak WSS. The FMD significantly increased from Q1 to Q4 according to the respective group, and differences were significant between any two groups (all *P* \<0.05). There was an increasing trend in NO, and decreasing trends in ET-1, ICAM-1, and VCAM-1 from Q1 to Q4. Compared with Q1, Q2, and Q3, the NO was significantly higher, and the ET-1, ICAM-1, and VCAM-1 were lower in Q4 (all *P* \<0.05).

Effect of mean WSS on renal function {#s2_2}
------------------------------------

Table [3](#T3){ref-type="table"} depicts the details of the estimated glomerular filtration rate base on creatinine (eGFR~Cr~), estimated glomerular filtration rate base on cystatin C (eGFR~CysC~), estimated glomerular filtration rate base on creatinine and cystatin C (eGFR~Cr-CysC~), and albumin/creatinine ratio (ACR) in the four groups classified by the interquartile of the mean WSS. The eGFR~Cr~, eGFR~CysC~, and eGFR~Cr-CysC~ significantly increased, and ACR decreased from Q1 to Q4, and difference were significant between any two groups (all *P* \<0.05).

###### Estimated glomerular filtration rates and albumin/creatinine ratio of participants grouped by the interquartile of carotid mean wall shear stress

  ---------------------------------------------------------------------------------------------------------------------------
                                        Q1\           Q2\               Q3\                 Q4\                   *P* value
                                        (*n*=192)     (*n*=189)         (*n*=190)           (*n*=190)             
  ------------------------------------- ------------- ----------------- ------------------- --------------------- -----------
  eGFR~Cr~, ml·min^-1^·1.73m^-2^        72.37±18.40   79.67±15.88^\*^   84.74±15.67^\*,†^   93.39±12.37^\*,†,‡^   \<0.001

  eGFR~CysC~, ml·min^-1^·1.73m^-2^      70.04±16.39   76.74±19.42^\*^   82.31±19.21^\*^     96.91±18.00^\*,†,‡^   \<0.001

  eGFR~Cr-CysC~, ml·min^-1^·1.73m^-2^   71.38±16.66   78.87±16.04^\*^   84.67±16.77^\*,†^   97.87±14.96^\*,†,‡^   \<0.001

  ACR, mg/g                             23.04±6.93    18.69±6.56^\*^    16.36±6.11^\*,†^    12.22±4.54^\*,†,‡^    \<0.001
  ---------------------------------------------------------------------------------------------------------------------------

Data are mean±standard deviation. Q1 indicates the first interquartile; Q2, the second interquartile; Q3, the third interquartile; Q4, the forth interquartile; eGFR~Cr~, estimated glomerular filtration rate base on creatinine; eGFR~CysC~, estimated glomerular filtration rate base on cystatin C; eGFR~Cr-CysC~, estimated glomerular filtration rate base on creatinine and cystatin C; ACR, albumin/creatinine ratio. ^\*^*P* \<0.05, as compared to Q1; ^†^*P* \<0.05, as compared to Q2; ^‡^*P* \<0.05, as compared to Q3.

The Pearson correlation analysis indicates that mean WSS was positively correlated with the eGFR~Cr~, eGFR~CysC~, and eGFR~Cr-CysC~, and inversely correlated with ACR (all *P* \<0.001, Figure [1](#F1){ref-type="fig"}).

![Correlations of carotid mean wall shear stress with the eGFR~Cr~, eGFR~CysC~, eGFR~Cr-CysC~, and ACR\
WSS indicates wall shear stress; eGFR~Cr~, estimated glomerular filtration rate base on creatinine; eGFR~CysC~, estimated glomerular filtration rate base on cystatin C; eGFR~Cr-CysC~, estimated glomerular filtration rate base on creatinine and cystatin C; ACR, albumin/creatinine ratio.](oncotarget-09-5251-g001){#F1}

Effect of peak WSS on renal function {#s2_3}
------------------------------------

We also assessed the effect of peak WSS on the renal function. [Supplementary Table 2](#SD1){ref-type="supplementary-material"} depicts the details of the eGFR~Cr~, eGFR~CysC~, eGFR~Cr-CysC~, and ACR in the four groups classified by the interquartile of the peak WSS. The eGFR~Cr~, eGFR~CysC~, and eGFR~Cr-CysC~ were markedly higher, and the ACR was lower in Q4 than in Q1, Q2, and Q3 (all *P* \<0.05). The eGFR~Cr~ and eGFR~Cr-CysC~ were markedly higher, the ACR was lower in Q2 and Q3 than in Q1 (all *P* \<0.05). The eGFR~CysC~ was higher in Q3 than in Q1 (*P* \<0.05).

Consistent with the mean WSS, the peak WSS was positively correlated with the eGFR~Cr~, eGFR~CysC~, and eGFR~Cr-CysC~, and inversely correlated with ACR (all *P* \<0.001, [Supplementary Figure 1](#SD1){ref-type="supplementary-material"})

Carotid WSS independently associated with renal function {#s2_4}
--------------------------------------------------------

To explore the association of mean WSS with renal function, we first adjusted for age and sex in model 1. We found that the mean WSS independently and positively associated with eGFR~Cr~, eGFR~CysC~, and eGFR~Cr-CysC~, and negatively related to ACR (all *P* \<0.001). For further identify these associations, we then adjusted for smoking and alcohol intake in model 2, and for body mass index, hypertension, antihypertensive medication, diabetes, lower glucose medication, dyslipidemia, anti-dyslipidemia medication, blood pressure, fasting blood glucose, blood lipids, and carotid artery plaque in model 3. The results showed that the independent associations were still remained (Table [4](#T4){ref-type="table"}).

###### Regression coefficients (95%) of carotid mean wall shear stress with renal function parameters

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
               eGFR~Cr~\                 eGFR~CysC~\              eGFR~Cr-CysC~\            ACR\                                                                       
               (ml·min^-1^·1.73m^-2^)    (ml·min^-1^·1.73m^-2^)   (ml·min^-1^·1.73m^-2^)    (mg/g)                                                                     
  ------------ ------------------------- ------------------------ ------------------------- --------- ------------------------- --------- ---------------------------- ---------
  Model 1^a^   18.696 (15.449, 21.943)   \<0.001                  30.194 (26.149, 34.239)   \<0.001   28.960 (25.288, 32.631)   \<0.001   -14.338 (-15.929, -12.748)   \<0.001

  Model 2^b^   18.972 (15.720, 22.224)   \<0.001                  30.347 (26.293, 34.402)   \<0.001   29.244 (25.568, 32.919)   \<0.001   -14.321 (-15.919, -12.724)   \<0.001

  Model 3^c^   17.840 (14.334, 21.346)   \<0.001                  23.394 (18.908, 27.880)   \<0.001   23.382 (19.677, 27.088)   \<0.001   -11.064 (-12.659, -9.469)    \<0.001
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

eGFR~Cr~ indicates estimated glomerular filtration rate base on creatinine; eGFR~CysC~, estimated glomerular filtration rate base on cystatin C; eGFR~Cr-CysC~, estimated glomerular filtration rate base on creatinine and cystatin C; ACR, albumin/creatinine ratio.

^a^Model 1: adjusted for age, sex.

^b^Model 2: model 1 + smoking and alcohol intake.

^c^Model 3: model 2 + body mass index, hypertension, diabetes, dyslipidemia, blood pressure, fasting blood glucose, blood lipids, and carotid artery plaque.

Similar to the mean WSS, the peak WSS was independently and positively associated with eGFR~Cr~, eGFR~CysC~, and eGFR~Cr-CysC~, and negatively related to ACR after adjustment for same confounders included in the models of the mean WSS ([Supplementary Table 3](#SD1){ref-type="supplementary-material"}).

Correlations between carotid WSS and biomarkers of endothelial function {#s2_5}
-----------------------------------------------------------------------

We also assessed the correlations of the mean WSS and peak WSS with the FMD, NO, ET-1, ICAM-1, and VCAM-1. We found that mean WSS (Table [5](#T5){ref-type="table"}) and peak WSS ([Supplementary Table 4](#SD1){ref-type="supplementary-material"}) were strong and positively related to FMD and NO, and negatively related to ET-1, ICAM-1, and VCAM-1 after adjustment for confounders in Table [1](#T1){ref-type="table"}, including age, sex, smoking, alcohol intake, body mass index, hypertension, antihypertensive medication, diabetes, lower glucose medication, dyslipidemia, anti-dyslipidemia medication, blood pressure, fasting blood glucose, blood lipids, and carotid artery plaque.

###### Correlations between carotid mean wall shear stress and biomarkers of endothelial function and inflammation

                                              Pearson correlation analysis   Partial correlations analysis^a^            
  ------------------------------------------- ------------------------------ ---------------------------------- -------- ---------
  Brachial artery flow-mediated dilation, %   0.637                          \<0.001                            0.557    \<0.001
  Nitric oxide, μmol/L                        0.643                          \<0.001                            0.551    \<0.001
  Endothelin-1, pg/ml                         -0.589                         \<0.001                            -0.489   \<0.001
  Intercellular adhesion molecule-1, ng/ml    -0.465                         \<0.001                            -0.350   \<0.001
  Vascular cell adhesion molecule-1, ng/ml    -0.428                         \<0.001                            -0.304   \<0.001

^a^ adjusted for age, sex, smoking, alcohol intake, body mass index, hypertension, diabetes, dyslipidemia, blood pressure, fasting blood glucose, blood lipids, and carotid artery plaque.

Correlations between renal function and biomarkers of endothelial function {#s2_6}
--------------------------------------------------------------------------

We also assessed the correlations of the FMD, NO, ET-1, ICAM-1, and VCAM-1 with the eGFR~Cr~, eGFR~CysC~, eGFR~Cr-CysC~, and ACR. We found that FMD and NO were positively related to eGFR~Cr~, eGFR~CysC~, and eGFR~Cr-CysC~, and negatively related to ACR, but ET-1, ICAM-1, and VCAM-1 were negatively related to eGFR~Cr~, eGFR~CysC~, and eGFR~Cr-CysC~, and positively related to ACR even after adjustment for age, sex, smoking, alcohol intake, body mass index, hypertension, antihypertensive medication, diabetes, lower glucose medication, dyslipidemia, anti-dyslipidemia medication, blood pressure, fasting blood glucose, blood lipids, and carotid artery plaque (Table [6](#T6){ref-type="table"}).

###### Correlations between renal function and biomarkers of endothelial function and inflammation

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                               eGFR~Cr~\                eGFR~CysC~\              eGFR~Cr-CysC~\           ACR\                                  
                                               (ml·min^-1^·1.73m^-2^)   (ml·min^-1^·1.73m^-2^)   (ml·min^-1^·1.73m^-2^)   (mg/g)                                
  -------------------------------------------- ------------------------ ------------------------ ------------------------ --------- -------- --------- -------- ---------
  A. Pearson correlation analysis                                                                                                                               

   Brachial artery flow-mediated dilation, %   0.536                    \<0.001                  0.497                    \<0.001   0.575    \<0.001   -0.504   \<0.001

   Nitric oxide, μmol/L                        0.513                    \<0.001                  0.529                    \<0.001   0.584    \<0.001   -0.503   \<0.001

   Endothelin-1, pg/ml                         -0.515                   \<0.001                  -0.486                   \<0.001   -0.554   \<0.001   0.476    \<0.001

   Intercellular adhesion molecule-1, ng/ml    -0.552                   \<0.001                  -0.417                   \<0.001   -0.527   \<0.001   0.440    \<0.001

   Vascular cell adhesion molecule-1, ng/ml    -0.400                   \<0.001                  -0.480                   \<0.001   -0.495   \<0.001   0.409    \<0.001

  B. Partial correlations analysis^a^                                                                                                                           

   Brachial artery flow-mediated dilation, %   0.380                    \<0.001                  0.344                    \<0.001   0.429    \<0.001   -0.366   \<0.001

   Nitric oxide, μmol/L                        0.350                    \<0.001                  0.374                    \<0.001   0.432    \<0.001   -0.355   \<0.001

   Endothelin-1, pg/ml                         -0.360                   \<0.001                  -0.329                   \<0.001   -0.400   \<0.001   0.326    \<0.001

   Intercellular adhesion molecule-1, ng/ml    -0.432                   \<0.001                  -0.226                   \<0.001   -0.363   \<0.001   0.264    \<0.001

   Vascular cell adhesion molecule-1, ng/ml    -0.268                   \<0.001                  -0.339                   \<0.001   -0.363   \<0.001   0.264    \<0.001
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------

^a^ adjusted for age, sex, smoking, alcohol intake, body mass index, hypertension, diabetes, dyslipidemia, blood pressure, fasting blood glucose, blood lipids, and carotid artery plaque. eGFR~Cr~ indicates estimated glomerular filtration rate base on creatinine; eGFR~CysC~, estimated glomerular filtration rate base on cystatin C; eGFR~Cr-CysC~, estimated glomerular filtration rate base on creatinine and cystatin C; ACR, albumin/creatinine ratio.

DISCUSSION {#s3}
==========

The primary objective of our study was to investigate the correlation of the carotid WSS with renal function in the elderly. The most important findings were those (1) the mean and peak carotid WSS were independently associated with eGFR derived from serum concentrations of creatinine and/or cystatin C using three CKD-EPI (the Chronic Kidney Disease Epidemiology Collaboration) equations and ACR after adjustment for confounders; (2) the carotid WSS was strongly related to endothelial function; and (3) the endothelial function was closely related to renal function. It indicates that rheologic forces may contribute to the crucial effects on renal dysfunction in the elderly. The effects may be mediated by regulation of endothelial function.

In the past decade, as regarding as an important factor of CKD, the hemodynamic has been increasingly emphasized. Verbeke and colleagues \[[@R23]\] reported that brachial artery WSS is significantly lower in patients with end-stage renal disease than in healthy subjects although their brachial artery blood flow is similar. In patients with CKD, the mean and maximum brachial artery wall shear rates were significantly lower than in healthy subjects \[[@R25]\]. Samijo and coworkers \[[@R24]\] assessed WSS in the CCA in end-stage renal failure patients. They found that mean WSS in end-stage renal failure patients who were prior to hemodialysis is significantly lower compared with presumed healthy age- and sex-matched control subjects. However, the studies did not clearly illuminate the relationship between WSS and renal function, and not deeply explore the mechanism of WSS on the renal function.

In the present study, we assessed the mean and peak carotid WSS in 761 community-dwelling elderly using a high-resolution ultrasound. We found that the minimum mean WSS of the right or left CCA was independently and positively correlated with eGFRs that estimated by creatinine and/or cystatin C, and negatively correlated with ACR even after adjustment for confounders. The similar findings were found between peak WSS and eGFRs and ACR. It demonstrates that carotid WSS may play an important role in renal function in the elderly.

It has been well characterized that the endothelial cells response to fluid shear stress \[[@R18]\]. WSS emerges as a major regulator of a large number of endothelial mediators. Under sustained high shear stress, vascular endothelial cells exhibit upregulation of vasodilator NO and down-regulation of vasoconstrictor ET-1, inflammatory adhesion molecules such as ICAM-1 and VCAM-1 \[[@R18]\]. Base on these mechanisms, brachial artery FMD is widely used as a simple and noninvasive clinical indicator of endothelial function \[[@R23]\].

To investigate the mechanism of WSS on the renal function, we investigated the correlations of carotid WSS with endothelial function. We found that the brachial artery FMD and serum NO were significantly higher, and the serum ET-1, ICAM-1, and VCAM-1 were lower in the highest WSS interquartile group than in the lowest WSS interquartile group. After adjusting for confounders, the carotid artery mean WSS and peak WSS were strongly correlated with these endothelial function biomarkers.

In addition, we also investigated the correlations between renal function and endothelial function in the present study. We found that renal function, assessed using eGFR and ACR, was closely related to endothelial function. Therefore, our findings suggested that the effect of carotid WSS on renal function may be mediated by regulation of endothelial function.

In the present study, ACR was used to assess the renal endothelial function as well as renal function. As is known that albuminuria, always represented by ACR, is a marker of renal endothelial dysfunction \[[@R27]\]. Albuminuria appears to link renal and cardiovascular organ damage. Meanwhile, albuminuria has been demonstrated to be strongly associated with systemic endothelial dysfunction in diabetic patients as well as in nondiabetic individuals \[[@R28], [@R29]\].

NO was used as one of biomarkers of endothelial function in the present study. There is argument about the relationship between NO and renal function. Bahadoran and coworkers \[[@R30]\] have reported that serum NO is independently associated with the risk of CKD in women. Higher level of serum NO metabolites, higher risk of CKD. However, most studies \[[@R31]--[@R33]\] demonstrated that NO deficiency contributes to progression of CKD. Similar findings were reported by Wever and colleagues who measured the ^15^N~2~-labeled arginine-to-citrulline conversion using the more direct approach \[[@R34]\]. We found that serum NO level was positively related to eGFRCr, eGFRCysC, and eGFRCr-CysC, and negatively related to ACR.

A strength of our study is that the eGFR was assessed using two new CKD-EPI equations to correct the imprecision of the common serum creatinine-based CKD-EPI equation. One is serum cystatin C-base eGFR equation and the other is cystatin C combined with creatinine-based equation. The precision of the two equations has been validated \[[@R35], [@R36]\]. In the present study, the eGFRs derived from the three equations were all closely related to carotid WSS. Another strength is that the minimum mean and peak WSS in both sides of CCA were used for analysis. Studies have demonstrated the lower WSS, the more likely to cause various vascular pathologic including impaired endothelial function \[[@R37]--[@R39]\].

Several limitations to this study should be considered. First, the study subjects were predominantly made up of Han recruited from the area of Shandong, China. There were essentially geographical limitations and no racial or ethnic minorities. Our findings need to validate in other ethnic groups and in different regions. Second, only CKD-EPI equations were applied to estimate the GFR. It may induce a certain bias. However, the accuracy of CKD-EPI equations has been validated in Chinese population \[[@R36]\]. Third, we did not address the causal relationship between carotid WSS and renal function owing to the cross-sectional nature of the study. Forth, the genetic background was not considered in the present study. Studies reported that genetic variants are significantly related to eGFR \[[@R40], [@R41]\]. Finally, the renal WSS was not assessed in the present study. There may be differences between the renal WSS and carotid artery WSS.

MATERIALS AND METHODS {#s4}
=====================

Study population {#s4_1}
----------------

From May 2009 to October 2012, a total of 761 older subjects aged 60 years and over \[mean and standard deviation (SD): 70.70±6.15 years\] were eligible and enrolled from community-dwelling in the Shandong area, China. Among them, 380 were women, and 381 were men. Subjects were excluded if they met any of the following exclusion criteria: end stage of renal disease, hemodialysis, cardio-cerebrovascular events including myocardial infarction and stroke in the previous 3 months, heart failure, secondary hypertension, active malignancy, abnormal liver enzymes (alanine aminotransferase and aspartate aminotransferase \>3 times than upper normal range), drug and alcohol abuse, and difficulty with providing informed consent.

This study was conducted in compliance with the "Declaration of Helsinki". The Research Ethics Committee of the Institute of Basic Medicine, Shandong Academy of Medical Sciences approved this study. Written informed consent was obtained from each subject.

Ultrasonography of CCA and calculation of WSS {#s4_2}
---------------------------------------------

The CCA ultrasound examinations were performed during morning hours in a quiet and temperature-controlled room (20-25 degrees Celsius). The subjects were demanded to discontinue tea, alcohol, caffeine, smoking, anti-histamine, nitrates, and calcium antagonists for 24 h and to fast for 12 h before the examination. After at least a 10-min acclimatization period, the examination was performed using a high-resolution ultrasound with a 7.5-MHz linear array transducer (Vivid *i*, GE Medical Systems Ultrasound Israel Ltd, Tirat Carmel, Israel) and electrocardiogram (ECG) triggering by an experienced ultrasonographer who was blinded to the subjects' clinical details.

CCA intima-media thickness was measured as the distance form the leading edge of the lumen-initima interface to the collagen-containing upper layer of the adventitia. Carotid artery plaque was defined as a intima-media thickness \>1.5 mm.

Accordance with previously described \[[@R20]\], the internal diameters of the CCA at the R (ID~R~) and peak T (ID~T~) waves on the ECG were measured using two-dimensionally guided continuous M-mode tracings. ID~R~ represents the minimum carotid diameter and ID~T~ indicates maximum carotid diameter. Mean velocity (V~M~) and peak systolic velocity (V~PS~), 1-2 cm below the bifurcation, were detected as the mean of three cardiac cycles.

Mean and peak WSS were calculated with the formula \[[@R20], [@R42]\]:

Mean WSS (Pa) = 8 × η × V~M~/ID~R~

Peak WSS (Pa) = 8 × η × V~PS~/ID~T~

where η is blood viscosity (Pa·s); V is the velocity (m/s); and ID is the lumen diameter (m). Viscosity is equal to 0.0035 Pa·s, as the carotid artery wall is always assumed to be rigid with blood as a Newtonian fluid \[[@R43]\]. Minimum mean and peak WSS in the right or left CCA were used for further analysis.

Brachial flow-mediated dilation measurement {#s4_3}
-------------------------------------------

Brachial artery FMD and CCA ultrasound examinations were performed on the same day. The details of the brachial artery FMD examination have been described in previous studies \[[@R44]--[@R46]\]. Briefly, the left brachial artery diameter was measured using a high-resolution ultrasound with a 7.5-MHz linear array transducer (Vivid *i*, GE Medical Systems Ultrasound Israel Ltd, Tirat Carmel, Israel) at rest and during reactive hyperemia. The reactive hyperemia was induced by inflation of a pneumatic tourniquet placed around the forearm to a pressure of 250 mm Hg for 5 min, followed by a release. Arterial diameter was assessed during the end-diastolic phase at a fixed distance from an anatomic marker at baseline and 60, 90, and 120 s after cuff deflation. The maximum diameter from the 3 assessments was used to calculate FMD. The calculation formula is as follows: FMD (%) = \[(maximum diameter - baseline diameter)/baseline diameter\] × 100 %.

Serum biomarkers of endothelial function and inflammation measurement {#s4_4}
---------------------------------------------------------------------

Fasting blood samples were obtained from all subjects and processed within 2 hours. Serum was collected and stored at -80 degrees Celsius until analysis. Serum NO was assessed by the quantification of nitrite using Griess assay \[[@R47]\]. The reagents were purchased from Sigma (St. Louis, MO, USA). Serum ET-1, VCAM-1, and ICAM-1 were measured using enzyme-linked immunosorbent assay (ELISA) kits following the manufacturer\'s instructions (Bender MedSystems, Vienna, Austria). All samples were tested in duplicate and the mean value was used for further analyze.

Evaluation of estimated glomerular filtration rate {#s4_5}
--------------------------------------------------

Renal function was evaluated by an eGFR which calculated from serum creatinine and/or Cystatin C level. Serum creatinine level was detected by the enzymic method (Shanghai Kehua Dongling Diagnostic Products Co., Ltd., China) and cystatin C was measured by the particle-enhanced immunoturbidimetry assay (Beijing Leadman Biomedical Co., Ltd., China) using a Hitachi 7600 automated biochemical analyzer. Three CKD-EPI equations for eGFR \[[@R35]\] were used in the present study:

The equation 1: eGFR~Cr~ (ml·min^-1^·1.73m^-2^) = 141 × min (Scr/κ, 1)^α^ × max (Scr/κ, 1)^-1.209^ × 0.993^Age^ \[× 1.018 if female\] \[× 1.159 if black\], where Scr is serum creatinine, κ is 0.7 for females and 0.9 for males, α is -0.329 for females and -0.411 for males, min is the minimum of Scr/κ or 1, and max is the maximum of Scr/κ or 1.

The equation 2: eGFR~CysC~ (ml·min^-1^·1.73m^-2^) = 133 × min (Scys/0.8, 1)^-0.499^ × max (Scys/0.8, 1)^-1.328^ × 0.996^Age^ \[× 0.932 if female\], where Scys is serum cystatin C, min indicates the minimum of Scys/κ or 1, and max indicates the maximum of Scys/κ or 1.

The equation 3: eGFR~Cr-CysC~ (ml·min^-1^·1.73m^-2^) = 135 × min(Scr/κ, 1) ^α^ × max(Scr/κ, 1)^-0.601^ × min(Scys/0.8, 1)^-0.375^ × max(Scys/0.8, 1)^-0.711^ × 0.995^Age^ \[× 0.969 if female\] \[× 1.08 if black\], where Scr is serum creatinine, Scys is serum cystatin C, κ is 0.7 for females and 0.9 for males, α is -0.248 for females and -0.207 for males, min indicates the minimum of Scr/κ or 1, and max indicates the maximum of Scr/κ or 1.

Evaluation of urinary albumin excretion {#s4_6}
---------------------------------------

Urinary albumin excretion was evaluated on the basis of the urinary ACR. Urinary albumin was tested by morning first void sterile urinary spot samples using immunonephelometry.

Statistical analysis {#s4_7}
--------------------

All statistical analyses were carried out using the SPSS for Windows software package, version 22.0 (SPSS Inc., Chicago, IL, USA). Continuous data were expressed as mean ±SD or as median with interquartile range (IQR, 25th and 75th percentiles) depending on the normality of the data. The normality was determined using the Kolmogorov--Smirnov test. Categorical data were expressed as numbers (percentages). Subjects were grouped by the interquartiles of either the mean WSS or peak WSS. The differences in continuous variables among the groups were assessed using one-way analysis of variance (ANOVA) with the Bonferroni procedure or the Kruskal--Wallis test with Wilcoxon rank-sum test. The differences in categorical variables among the groups were assessed using the chi-square test. Pearson correlation coefficients were used to assess the relationships of the mean WSS and peak WSS to eGFR~Cr~, eGFR~CysC~, eGFR~Cr-CysC~, and ACR. Partial correlations analysis was used to determined the relationships of the mean WSS and peak WSS to FMD, NO, ET-1, ICAM1, and VCAM1, and the relationships of the FMD, NO, ET-1, ICAM1, and VCAM1 to eGFR~Cr~, eGFR~CysC~, eGFR~Cr-CysC~, and ACR. A multiple linear regression analysis was performed to determine if any factors were independently associated with renal function. Mean WSS and peak WSS were included as an independent factor, respectively, in the regression models. Model 1 was adjusted for age, sex. Model 2 was further adjusted for smoking and alcohol intake, and model 3 was further adjusted for body mass index, hypertension, antihypertensive medication, diabetes, lower glucose medication, dyslipidemia, anti-dyslipidemia medication, blood pressure, fasting blood glucose, and blood lipids. A *P*-value of \<0.05 was considered to be significant.

CONCLUSIONS {#s5}
===========

In conclusion, there is an independent correlation of carotid WSS with renal function in the elderly. The rheologic forces may play an important role in renal function changing. The correlation may be mediated by regulation of endothelial function. The multi-racial, multi-ethnic, multi-geographic, and longitudinal studies are needed to clarify the role of carotid WSS in CKD.

SUPPLEMENTARY FIGURE AND TABLES {#s6}
===============================
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CKD

:   chronic kidney disease

CCA

:   common carotid artery

WSS

:   wall shear stress

eGFR

:   estimated glomerular filtration rate

ACR

:   albumin/creatinine ratio

Cr

:   creatinine

Cys C

:   cystatin C

UA

:   urinary albumin

FMD

:   flow-mediated dilation
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:   nitric oxide

ET-1

:   endothelin-1
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:   intercellular adhesion molecule-1

VCAM-1

:   vascular cell adhesion molecule-1

CKD-EPI

:   the Chronic Kidney Disease Epidemiology Collaboration.
